相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries
Eloisa Rubio-Beltran et al.
CEPHALALGIA (2020)
CGRP and the Trigeminal System in Migraine
Smriti Iyengar et al.
HEADACHE (2019)
Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class
Richard Hargreaves et al.
HEADACHE (2019)
Ischemic Stroke Associated With Calcitonin Gene-Related Peptide Inhibitor Therapy for Migraine: A Case Report
Stephen Aradi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2019)
Fremanezumab inhibits vasodilatory effects of CGRP and capsaicin in rat cerebral artery - Potential role in conditions of severe vasoconstriction
Anne-Sofie Grell et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Simona Sacco et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive Infection
Felipe A. Pinho-Ribeiro et al.
CELL (2018)
CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine
Kasra Maasumi et al.
DRUGS (2018)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
Christophe Depre et al.
HEADACHE (2018)
Endogenous calcitonin gene-related peptide suppresses ischemic brain injuries and progression of cognitive decline
Liuyu Zhai et al.
JOURNAL OF HYPERTENSION (2018)
CGRP as the target of new migraine therapies - successful translation from bench to clinic
Lars Edvinsson et al.
NATURE REVIEWS NEUROLOGY (2018)
A unique inbred rat strain with sustained cephalic hypersensitivity as a model of chronic migraine-like pain
Gordon Munro et al.
SCIENTIFIC REPORTS (2018)
Intranasal Calcitonin Gene-Related Peptide Protects Against Focal Cerebral Ischemic Injury in Rats Through the Wnt/beta-Catenin Pathway
Zhenlan Du et al.
MEDICAL SCIENCE MONITOR (2018)
Is CGRP Receptor Blockade Cardiovascularly Safe? Appropriate Studies Are Needed
A. Maassen van den Brink et al.
HEADACHE (2018)
Erenumab (AMG 334) in episodic migraine Interim analysis of an ongoing open-label study
Messoud Ashina et al.
NEUROLOGY (2017)
Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries
Majid Sheykhzade et al.
VASCULAR PHARMACOLOGY (2017)
Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats
V. H. Aviles-Rosas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Transient Receptor Potential Vanilloid Subtype 1 Inhibits Inflammation and Apoptosis via the Release of Calcitonin Gene-Related Peptide in the Heart after Myocardial Infarction
Jiayan Lei et al.
CARDIOLOGY (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Comment on A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Kristian Agmund Haanes et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Sensitivity to acute cerebral ischemic injury in migraineurs A retrospective case-control study
Jerome Mawet et al.
NEUROLOGY (2015)
SPREADING DEPRESSION, SPREADING DEPOLARIZATIONS, AND THE CEREBRAL VASCULATURE
Cenk Ayata et al.
PHYSIOLOGICAL REVIEWS (2015)
Migraine and stroke: In search of shared mechanisms
Jerome Mawet et al.
CEPHALALGIA (2015)
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
Ronald Marcus et al.
CEPHALALGIA (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Calcitonin gene-related peptide protects the myocardium from ischemia induced by endothelin-1: Intravital microscopic observation and 31P-MR spectroscopic studies
Satoshi Homma et al.
LIFE SCIENCES (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain
R. J. Benschop et al.
OSTEOARTHRITIS AND CARTILAGE (2014)
TRPA1 is essential for the vascular response to environmental cold exposure
Aisah A. Aubdool et al.
NATURE COMMUNICATIONS (2014)
The CGRP receptor antagonist BIBN4096BS peripherally alleviates inflammatory pain in rats
Silke Hirsch et al.
PAIN (2013)
Migraine Mutations Increase Stroke Vulnerability by Facilitating Ischemic Depolarizations
Katharina Eikermann-Haerter et al.
CIRCULATION (2012)
A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
B. R. Chaitman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
Tony W. Ho et al.
HEADACHE (2012)
Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine
Guanglin Luo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Migraine and stroke: a complex association with clinical implications
Tobias Kurth et al.
LANCET NEUROLOGY (2012)
Differential effects of calcitonin gene-related peptide receptor blockade by olcegepant on mechanical allodynia induced by ligation of the infraorbital nerve vs the sciatic nerve in the rat
Benoit Michot et al.
PAIN (2012)
Leptin attenuates cerebral ischemia/reperfusion injury partially by CGRP expression
Jin-ying Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion
Zhen Liu et al.
REGULATORY PEPTIDES (2011)
High Cortical Spreading Depression Susceptibility and Migraine-Associated Symptoms in Ca(V)2.1 S218L Mice
Arn M. J. M. van den Maagdenberg et al.
ANNALS OF NEUROLOGY (2010)
CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine
J. F. Tvedskov et al.
CEPHALALGIA (2010)
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
Lars Edvinsson et al.
CEPHALALGIA (2010)
Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
K. Y. Chan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
L. Edvinsson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Characterisation of CGRP receptors in the human isolated middle meningeal artery
Saurabh Gupta et al.
LIFE SCIENCES (2006)
Characterisation of CGRP receptors in human and porcine isolated coronary arteries:: Evidence for CGRP receptor heterogeneity
S Gupta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo
KA Petersen et al.
CEPHALALGIA (2005)
Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay
JC Hershey et al.
REGULATORY PEPTIDES (2005)
BIBN4096BS antagonizes human α-calcitonin gene related peptide-induced headache and extracerebral artery dilatation
KA Petersen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers
KA Petersen et al.
CEPHALALGIA (2005)
Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice
JL Chen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
M Iovino et al.
CEPHALALGIA (2004)
Vascular actions of calcitonin gene-related peptide and adrenomedullin
SD Brain et al.
PHYSIOLOGICAL REVIEWS (2004)
Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat
KA Petersen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists
JJ Mallee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Potential of calcitonin gene-related peptide in coronary heart disease
A Franco-Cereceda et al.
PHARMACOLOGY (2000)
分享论文
